Chumpradit S, Kung M P, Vessotskie J, Foulon C, Mu M, Kung H F
Department of Radiology, University of Pennsylvania, Philadelphia 19104.
J Med Chem. 1994 Nov 25;37(24):4245-50. doi: 10.1021/jm00050a021.
In developing selective ligands for dopamine D2 and D3 receptors, several iodinated 2-aminotetralins and 3-amino-1-benzopyrans, trans-7-hydroxy-2-[N-(3'-iodo-2'- propenyl)amino]tetralin (1), trans-monohydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin (7-, 5-, and 6-OH-PIPAT) (2, 3, and 4), and trans-monohydroxy-3,4-dihydro-3-[N-propyl-N-(3'-iodo-2'- propenyl)-amino]-2H-1-benzopyran (6- and 8-OH-benzopyrans) (5 and 6), were prepared. These compounds were evaluated for their binding profiles in several membrane preparations: Spodoptera frugiperda (Sf9) cells expressing dopamine D2 (non-GTP coupled, low-affinity states) and D3 receptors, HEK293 cells expressing dopamine D2 receptors in high-affinity states (D2H), rat hippocampal homogenates for 5-HT1A receptors, and cerebellar homogenates for sigma receptors. The mono-N-alkylated 2-aminotetralin, 1, displayed high sigma binding (Ki = 1.68 nM) with a moderate D3 binding (Ki = 30.2 nM). Derivatives with one N-propyl and one N-(3'-iodo-2'-propeny) group generally displayed high to moderate affinity to D3 receptors (Ki = 2.90, 1.85, 0.99, 2.20, 31.4, and 6.69 nM for 7-OH-DPAT [7-hydroxy-2-(N,N-di-n-propylamino)tetralin], 2, 3, 4, 5, and 6, respectively). It is interesting to note that all of the active D3 ligands also displayed comparable binding to the high affinity states of D2 receptors in HEK293 cells (Ki = 6.6, 3.6, 9.7, and 10.8 nM for 2, 3, 4, and 6, respectively). Among all of the tetralin derivatives tested, 5-OH-PIPAT, 3, showed the highest binding affinity to D3 receptors (Ki = 0.99 nM) and better selectivity (KiD2H/KiD3, KiD2/KiD3, Ki5-HT1A/KiD3 and Ki sigma/KiD3 = 3.64, 327, 48.4, and 1250 nM, respectively), making it the best ligand for studying dopamine D2H and D3 receptors.
在开发多巴胺D2和D3受体的选择性配体过程中,制备了几种碘化的2-氨基四氢萘和3-氨基-1-苯并吡喃,反式-7-羟基-2-[N-(3'-碘-2'-丙烯基)氨基]四氢萘(1)、反式单羟基-2-[N-丙基-N-(3'-碘-2'-丙烯基)氨基]四氢萘(7-、5-和6-OH-PIPAT)(2、3和4)以及反式单羟基-3,4-二氢-3-[N-丙基-N-(3'-碘-2'-丙烯基)-氨基]-2H-1-苯并吡喃(6-和8-OH-苯并吡喃)(5和6)。在几种膜制剂中评估了这些化合物的结合特性:表达多巴胺D2(非GTP偶联、低亲和力状态)和D3受体的草地贪夜蛾(Sf9)细胞、表达高亲和力状态多巴胺D2受体(D2H)的HEK293细胞、用于5-HT1A受体的大鼠海马匀浆以及用于σ受体的小脑匀浆。单-N-烷基化的2-氨基四氢萘1表现出高的σ结合(Ki = 1.68 nM)和中等的D3结合(Ki = 30.2 nM)。具有一个N-丙基和一个N-(3'-碘-2'-丙烯基)基团的衍生物通常对D3受体表现出高至中等亲和力(7-OH-DPAT [7-羟基-2-(N,N-二正丙基氨基)四氢萘]、2、3、4、5和6的Ki分别为2.90、1.85、0.99、2.20、31.4和6.69 nM)。有趣的是,所有活性D3配体在HEK293细胞中对D2受体的高亲和力状态也表现出相当的结合(2、3、4和6的Ki分别为6.6、3.6、9.7和10.8 nM)。在所有测试的四氢萘衍生物中,5-OH-PIPAT 3对D3受体表现出最高的结合亲和力(Ki = 0.9 nM)和更好的选择性(KiD2H/KiD3、KiD2/KiD3、Ki5-HT1A/KiD3和Kiσ/KiD3分别为3.64、327、48.4和1250 nM),使其成为研究多巴胺D2H和D3受体的最佳配体。